Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
05/2005
05/25/2005CN1618794A Production method of ethofumesate
05/25/2005CN1203066C (Methylsulfonyl) phenyl-2-(5H)-furanones as cos-2 inhibitors
05/25/2005CN1203047C Biaryl ether derivatives useful as monoamine reuptake inhibitors
05/25/2005CN1202864C Use of CD40:CD154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection
05/24/2005US6897331 Fluorous triphase and other multiphase systems
05/24/2005US6897240 Thio semicarbazone and semicarbazone inhibitors of cysteine proteases and methods of their use
05/24/2005US6897232 Activate soluble guanylate cyclase; for use treating cardiovascular disorders, erectile dysfunction, diabetes, and cirrhosis of the liver, kidney disorders, and learning disability
05/24/2005US6897220 Antiproliferative agents
05/24/2005CA2324306C Polyethoxylated ascorbic acid derivatives as a novel antioxidant and process for preparing thereof
05/19/2005WO2005044812A1 Dihydrobenzofuranyl alkanamine derivatives as 5ht2c agonists
05/19/2005WO2005044787A1 Phenetanolamine derivatives
05/19/2005WO2005044007A1 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient
05/19/2005WO2005021496A3 Synthesis of derivatives of ginkgolide c
05/19/2005WO2005020917A3 Ophthalmic compositions for treating ocular hypertension
05/19/2005WO2005015158A9 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
05/19/2005WO2005012220A9 Cycloalkylidene compounds as modulators of estrogen receptor
05/19/2005WO2005005956A3 Fluorophore compounds and their use in biological systems
05/19/2005WO2004092100A8 Indene derivatives as pharmaceutical agents
05/19/2005US20050107448 Calcium receptor antagonists
05/19/2005US20050107445 Active compounds with carbamic acid for diseases such as cancer, leukemia, atheriosclerosis, alzheimers disease or arthritis
05/19/2005US20050107444 E.g., 2-(3-{3-[(2-chloro-3-(trifluoromethyl)-benzyl)-(2,2-diphenylethyl)-amino]-propoxy}phenyl)-1-morpholin-4-yl-ethanone; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption
05/19/2005US20050107384 to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a HDAC in a biological sample comprising detecting or measuring the formation of a complex between a labelled compound as defined in claim (I) and a HDAC
05/19/2005US20050107383 such as 2-(2-propenylthio)-4-(4-trifluoromethylphenyl)benzonitrile; for farm and garden pests including mites, lepidopterans, hemipterans, hymenopterans, orthopterans and isopterans; antiviral agent, fungicide, herbicide
05/19/2005US20050107379 antithrombolytic agents such as (E)-2-(5-Chlorothien-2-yl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide, used for therapy of cardiovascular disorders
05/19/2005US20050107348 Contacting cells with a zinc-binding compounds, having effective amount of carboxylic acid derivative or hydroxamic acid derivative inhibitor compound; treating cancer, blood disorders, genetic related metabolic disorders; 3-methyl-5-phenyl-2,4-pentadienoic acid
05/19/2005US20050107334 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
05/19/2005US20050106414 9,9-Dimethylfluorene trimers capped with aromatic amine groups used to produce an organic light-emitting device that exhibits an extremely pure luminescent hue and has a light emission of high efficiency, high brightness, and long lifetime
05/19/2005US20050104233 Method of substituent introduction through halogen-metal exchange reaction
05/19/2005DE10348044A1 Duale Alanyl-Aminopeptidase- und Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen Dual-alanyl aminopeptidase and dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
05/19/2005DE10348023A1 Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New alanyl aminopeptidase inhibitors for functional interference of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
05/19/2005CA2542878A1 Dihydrobenzofuranyl alkanamine derivatives as 5ht2c agonists
05/18/2005EP1530564A2 Compounds derived from aryl carbamates, preparation thereof and uses of same
05/18/2005EP1530430A2 Method for producing an avocado unsaponifiable rich in furan lipids
05/18/2005EP1351949B1 Continuous process for producing l-ascorbic acid
05/18/2005EP1301502B1 Compounds and their use as glycine transport inhibitors
05/18/2005EP1176139B1 Medicinal compositions with 2.2.1] and 3.1.1] bicycloskeleton antagonistic to both of pgd 2?/txa 2? receptors
05/18/2005CN1617866A Preparation of substituted phthalic anhydrides and substituted phthalimides
05/18/2005CN1617852A Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
05/18/2005CN1616446A Polysubstituted benzo hetero aromatic ring and method for one step synthesizing polysubstituted benzo hetero aromatic ring
05/18/2005CN1616445A Method for synthesizing saturated fatty acid vitamin C ester
05/18/2005CN1616444A Unsaturated lactone compound and its preparing method and use
05/18/2005CN1616443A Process and device for producing furol by two step continuous low pressure high temperature dynamic hydrolysis method
05/18/2005CN1616432A Compound, its use and pharmaceutical compositions comprising same
05/18/2005CN1202108C Spiro compounds, preparing method and intermediate
05/18/2005CN1202103C Preparation method of red sageroot total phenolic acid
05/18/2005CN1202102C Method for the production of 2-coumarone and substituted 2-coumarones
05/18/2005CN1202101C Medicinal compound with anti-infection, anti-inflammatory and antipyretic, and improving immunity function
05/18/2005CN1202100C Synthetic method for (S)-3-hydroxy-gamma-butyrolactone
05/18/2005CN1202052C Enantioselective reduction of ketones with silane agent/metal compound/chiral ligand system
05/17/2005US6894185 Substituted chiral allosteric hemoglobin modifiers
05/17/2005US6894177 Viricides; human immunodeficiency virus
05/17/2005US6894173 Intermediates useful for synthesis of heteroaryl-substituted urea compounds, and processes of making same
05/17/2005US6894160 Converting sugars such as glucose and fructose into industrial useful products via hydrogenation and reductive amination using platinum catalyst formed from stabilized nanoparticles
05/17/2005US6894072 Compounds as NS3-serine protease inhibitors of hepatitis C virus
05/17/2005US6894059 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
05/17/2005US6894005 Heterocyclic compound containing phenyl groups; postemergence herbicides
05/17/2005US6893650 Fungicides; locus infestation; such as N,N-dimethyl-N'-(4-(3-trifluoromethylbenzylthio)-2,5-xylyl)formamidine
05/17/2005CA2136597C Hydrazine derivatives and uses thereof
05/17/2005CA2103845C 9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines
05/12/2005WO2005043124A2 Chiral 1,8-diarylnaphthalenes, methods of making them, and their use as sensors
05/12/2005WO2005042513A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
05/12/2005WO2005042507A1 Bis {6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, (4e)-4-hexenoic acid} zinc salt
05/12/2005WO2005042494A1 Isopentyl carboxanilides for combating undesired micro-organisms
05/12/2005WO2005042493A1 Hexyl carboxanilides and their use for controlling undesirable micro-organisms
05/12/2005WO2005042492A1 1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organisms
05/12/2005WO2005042474A1 Diamine derivative, process for producing the same, and plant disease control agent containing the same as active ingredient
05/12/2005WO2005042473A1 Improved process for the manufacture of citalopram hydrobromide
05/12/2005WO2005042464A1 Androgen receptor modulators
05/12/2005WO2005041684A2 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
05/12/2005WO2005007635A8 Combretastatin derivatives with cytotoxic action
05/12/2005WO2004092145A8 Alpha substituted carboxylic acid as ppar modulators
05/12/2005WO2004087061B1 Tubulin binding agents and corresponding prodrug constructs
05/12/2005WO2004022775A8 Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use
05/12/2005WO2003006454A8 Heterocyclic carboxamides and their use as fungicides
05/12/2005US20050101787 Reaction of metal complex and nitrogen compound to form nitro or nitrile complex
05/12/2005US20050101665 Treatment of neurotic disorders
05/12/2005US20050101642 Niacinamide derivatives as inhibitor of poly(ADP-ribose)polymerase; ranitidine, cimetidine, famotidine, nizatidine as gastric acid secretion control; immunomodulation and suppression of hypersensitivity and inflammatory reaction; IgE mediated allergic reaction; no side effects; virtually non-toxic
05/12/2005US20050101575 Vitamin d3 derivatives and remedies using the same
05/12/2005US20050101541 Lignan derivatives
05/12/2005US20050101540 STAT modulators
05/12/2005US20050100805 Electrophotographic photosensitive member, process cartridge and electrophotographic apparatus
05/12/2005US20050098762 4,6,7-Trifluoro-benzo[b]naphtho[2,3-d]furan derivatives
05/12/2005CA2546422A1 Improved process for the manufacture of citalopram hydrobromide
05/12/2005CA2543345A1 Androgen receptor modulators
05/12/2005CA2543054A1 Isopentylcarboxanilides for combating undesired micro-organisms
05/12/2005CA2540843A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
05/12/2005CA2535036A1 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
05/11/2005EP1529530A1 Compounds affecting glucokinase
05/11/2005EP1529039A2 Method for producing maleic anhydride
05/11/2005EP0951464B1 N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
05/11/2005EP0945450B1 Fused heterocyclic benzenecarboxylic acid amide derivatives and pgd2 antagonists containing the same
05/11/2005EP0861071B1 Benzamidoxime prodrugs and use thereof for treating pneumonia
05/11/2005CN1615331A Methods for the preparation of poly(etherimides)s
05/11/2005CN1615311A 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
05/11/2005CN1613856A Synthesis for organic sulfur compound in hydrous medium
05/11/2005CN1613853A PDF enzyme inhibitor-hydroxamic acid serial compounds synthetic method and use thereof
05/11/2005CN1200935C Method for preparing benzofuran or benzothiophene compound
05/11/2005CN1200704C Appliance of probucol monoesters for treatment of cardiovascular and inflammatory disease
05/10/2005US6891072 Process for production of dimers or aromatic monohydroxyl compounds
05/10/2005US6890956 Cyclohexyl sulphones as gamma-secretase inhibitors
1 ... 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 ... 472